About me
Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines academic research, most recently at the University of Washington, with senior biotech industry experience prior to becoming CEO of Vaxdyn.
